Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 10,138

The researchers conducted in-depth analyses of how touch signals are transferred and processed in neurons of various parts of the brain and the latest studies have been published in Cell Reports and Frontiers in Cellular Neuroscience. The experiments were conducted on anaesthetised rats.

“We immediately realised that our findings deviated strongly from the accepted view that different parts of the brain are responsible for different specific functions,” says Henrik Jörntell, one of the researchers behind the study.

Read more

A drug commonly used to treat multiple sclerosis may, after necessary modifications, one day be used to treat patients with epilepsy, researchers in Prof. Inna Slutsky’s lab at the Sackler Faculty of Medicine and Sagol School of Neuroscience at Tel Aviv University have discovered.

This is good news for patients with Dravet syndrome, one of the most dangerous forms of childhood epilepsy, for which there is currently no .

According to a new study published on April 29 in Neuron, Tel Aviv University researchers uncovered a piece of a puzzle that has eluded scientists for 100 years of studying homeostasis: What is the mechanism that maintains activity set points in ?

Read more

New data from the Hubble Space Telescope confirms that the universe is expanding nine percent more rapidly than theoretical calculations predicted.

Those original calculations were based on data from the early universe, so many scientists suspected that something sped up the works. But the new Hubble data suggests that the universe could be substantially younger than previously believed — perhaps by as much as a billion years, according to the Associated Press.

Read more

The recent clinical trial was only conducted on patients with lymphoma, but the researchers suggested their approach could be potentially used to treat other types of cancer — and that it could improve the efficacy of other immunotherapies, including checkpoint blockade.

“The in situ vaccine approach has broad implications for multiple types of cancer,” said Brody, the study’s lead author and the director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai. “This method could also increase the success of other immunotherapies such as checkpoint blockade.”

Related Articles Around the Web.

Read more